Repligen Corp

RGENNASDAQUSD
147.25 USD
1.30 (0.88%)AT CLOSE (11:59 AM EDT)
147.20
0.06 (0.04%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
147.20
0.06 (0.04%)
🔴Market: CLOSED

Repligen Corp (RGEN) trades at $147.25 per share. Both sides of the analysis agree: technicals flash "Strong Buy" and fundamentals confirm with a "Buy" reading. Key drivers include a robust Altman Z-Score and a bearish Death Cross on the long-term moving averages. Furthermore, RGEN is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jul 17, 2026.

Open?$147.11
High?$149.06
Low?$143.88
Prev. Close?$148.55
Volume?912.4K
Avg. Volume?1.0M
VWAP?$146.38
Rel. Volume?0.90x
Bid / Ask
Bid?$134.77 × 200
Ask?$152.00 × 300
Spread?$17.23
Midpoint?$143.39
Valuation & Ratios
Market Cap?8.3B
Shares Out?56.4M
Float?55.9M
Float %?99.2%
P/E Ratio?161.61
P/B Ratio?3.94
EPS?$0.91
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Employees
2.0K
Market Cap
8.4B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
1986-04-29
Address
41 SEYON STREET
WALTHAM, MA 02453
Phone: (781) 449-9560
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
100
Momentum?
73
Short Sent.?
35
Piotroski F-Score?6/9Mixed
Altman Z-Score?7.02Safe
Confidence?61%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?10.82%High
Short Interest?6.0M
Days to Cover?4.7
Free Float55.9M
Avg Daily Volume1.3M
Settlement Date2026-06-30
Financial Health
Current Ratio?9.20Strong
Quick Ratio?7.78Strong
Cash Ratio?4.62Strong
Debt/Equity?0.26Low
ValuationRICHLY VALUEDvs 7 peers + S&P 500
Score
39/100
P/E?
Peers
13
S&P
3
161.6PRICEY
P/B?
Peers
43
S&P
45
3.94FAIR
P/S?
Peers
13
S&P
7
10.88HIGH
P/FCF?
Peers
13
S&P
3
78.3PRICEY
EV/EBITDA?
Peers
13
S&P
3
59.4HIGH
EV/Sales?
Peers
13
S&P
9
10.83HIGH
Returns & Efficiency
ROE?
Peers
14
S&P
17
2.4%WEAK
ROA?
Peers
25
S&P
18
1.8%WEAK
Cash Flow & Enterprise
FCF?$106.0M
Enterprise Value?$8.3B
Fundamentals ratios updated end of day